Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Immunology Letters|June 1, 2013
Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinomaIvo Minárik, Jan Lašťovička, Vít Budinský, et al.
Urologia Internationalis|May 9, 2019
Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate BiopsyMiroslav Záleský, Jiri Stejskal, Vanda Adamcova, et al.
In Vivo (Athens, Greece)|February 25, 2018
Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological TumorsKaterina Duskova, Stepan Vesely, Joana DO Carmo Silva, et al.
International Journal of Cancer|April 23, 2020
Bladder cancer therapy without toxicity-A dose-escalation study of alpha1-oleateTran Thi Hien, Ines Ambite, Daniel Butler, et al.
Urologia Internationalis|August 30, 2014
Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 casesJan Hrbáček, Petr Macek, Bedeir Ali-El-Dein, et al.
Cancer & Metabolism|June 24, 2026
Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissueFarhan Haq, Siddharth Chinchankar, Ines Ambite, et al.
Cancer Medicine|March 30, 2024
Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancerShahram Ahmadi, Ines Ambite, Antonín Brisuda, et al.
Cancers|October 23, 2020
Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder TumoursMathieu Roumiguié, Evanguelos Xylinas, Antonin Brisuda, et al.
International Journal of Cancer|March 9, 2023
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapyTran Thi Hien, Ines Ambite, Murphy Lam Yim Wan, et al.
European Urology Focus|November 3, 2023
Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled StudyFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
Pageof 8